Helsinn and Eisai extend partnership for prevention of CINV

Helsinn and Eisai will continue to co-promote and distribute Aloxi (palonosetron HCl) injection for the prevention of chemotherapy-induced nausea and vomiting (CINV).
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news